Insider · CIK 0001728920
Francisco Leon
Files at PRVB (Provention Bio, Inc.). First filing Dec 27, 2022, latest Feb 14, 2023.
In brief
Francisco Leon files SEC Form 4 as officer at PRVB (Provention Bio, Inc.). Since Dec 27, 2022, Francisco Leon has reported 0 open-market buys worth $0 and 5 open-market sells worth $3.1M, the latest filed on Feb 14, 2023.
A track record needs three past buys with six months of prices behind them; Francisco Leon has 0, so none is measured yet.
The newest scored trade: sold $767k of PRVB on Feb 10, 2023, filed Feb 14, 2023, scored 17 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Provention Bio, Inc. | $767k 75,985 shares | -5% | - | |
| 8Weak | Provention Bio, Inc. | $247k 24,015 shares | -2% | - | |
| 30Weak | PRVBsell Provention Bio, Inc. | $1.9M 187,000 shares | -11% | - | |
| 10Weak | PRVBsell Provention Bio, Inc. | $107k 10,674 shares | -1% | - | |
| 0Weak | PRVBsell Provention Bio, Inc. | $19k 1,943 shares | -0% | - |
Transactions
Every row this insider has filed, 35 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | PRVB Provention Bio, Inc. | UTender of shares Common Stock | -73,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | UTender of shares Common Stockindirect: By Immunosoma LLC | -1,500,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | UTender of shares Common Stockindirect: By Trust | -1,000,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -242,103 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -400,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -137,750 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -139,500 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -145,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -210,000 | - | - | 0 | Apr 27, 2023 |
| Apr 13, 2023 | PRVB Provention Bio, Inc. | GGift Common Stock | -1,500,000 | $0.00 | $0 | 73,000 | Apr 14, 2023 |
| Apr 13, 2023 | PRVB Provention Bio, Inc. | GGift Common Stockindirect: By Immunosoma LLC | +1,500,000 | $0.00 | $0 | 73,000 | Apr 14, 2023 |
| Feb 10, 2023 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +50,000 | $2.50 | $125k | 1,623,000 | Feb 14, 2023 |
| Feb 10, 2023 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -50,000 | $10.11 | $506k | 1,573,000 | Feb 14, 2023 |
| Feb 13, 2023 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +25,985 | $2.50 | $65k | 1,598,985 | Feb 14, 2023 |
| Feb 13, 2023 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -25,985 | $10.04 | $261k | 1,573,000 | Feb 14, 2023 |
| Feb 10, 2023 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 268,088 | Feb 14, 2023 |
| Feb 13, 2023 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -25,985 | $0.00 | $0 | 242,103 | Feb 14, 2023 |
| Jan 18, 2023 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +24,015 | $2.50 | $60k | 1,597,015 | Jan 20, 2023 |
| Jan 18, 2023 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -24,015 | $10.27 | $247k | 1,573,000 | Jan 20, 2023 |
| Jan 18, 2023 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -24,015 | $0.00 | $0 | 318,088 | Jan 20, 2023 |
| Jan 10, 2023 | PRVB Provention Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +210,000 | $0.00 | $0 | 210,000 | Jan 11, 2023 |
| Dec 29, 2022 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +187,000 | $2.50 | $468k | 1,760,000 | Dec 30, 2022 |
| Dec 29, 2022 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock | -187,000 | $10.26 | $1.9M | 1,573,000 | Dec 30, 2022 |
| Dec 29, 2022 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -187,000 | $0.00 | $0 | 342,103 | Dec 30, 2022 |
| Dec 27, 2022 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +10,674 | $2.50 | $27k | 1,583,674 | Dec 29, 2022 |
| Dec 27, 2022 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock | -10,674 | $10.00 | $107k | 1,573,000 | Dec 29, 2022 |
| Dec 27, 2022 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -10,674 | $0.00 | $0 | 529,103 | Dec 29, 2022 |
| Dec 22, 2022 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +1,568 | $2.50 | $3,920 | 1,574,568 | Dec 27, 2022 |
| Dec 22, 2022 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock | -1,568 | $10.00 | $16k | 1,573,000 | Dec 27, 2022 |
| Dec 23, 2022 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +375 | $2.50 | $938 | 1,573,375 | Dec 27, 2022 |
| Dec 23, 2022 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock | -375 | $10.00 | $3,750 | 1,573,000 | Dec 27, 2022 |
| Dec 22, 2022 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -1,568 | $0.00 | $0 | 540,152 | Dec 27, 2022 |
| Dec 23, 2022 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -375 | $0.00 | $0 | 539,777 | Dec 27, 2022 |
| Dec 8, 2022 | PRVB Provention Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,663 | $0.00 | $0 | 75,763 | Dec 9, 2022 |
| Nov 22, 2022 | PRVB Provention Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 400,000 | Nov 23, 2022 |
Questions about Francisco Leon
Answered from the filings on this page, as of the latest one.
Is Francisco Leon buying or selling?
Not in the last 12 months. Francisco Leon's latest open-market trade on SEC Form 4 was sold $767k of PRVB on Feb 10, 2023.
How did Francisco Leon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Francisco Leon has 0.
Where does Francisco Leon file Form 4?
Francisco Leon has filed Form 4 at PRVB (Provention Bio, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.